[HTML][HTML] Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
TH Harju, MJ Peltoniemi, PH Rytilä, Y Soini… - Respiratory …, 2007 - Springer
Respiratory research, 2007•Springer
Background The major contribution to oxidant related lung damage in COPD is from the
oxidant/antioxidant imbalance and possibly impaired antioxidant defence. Glutathione
(GSH) is one of the most important antioxidants in human lung and lung secretions, but the
mechanisms participating in its homeostasis are partly unclear. Glutathione-S-transferase
omega (GSTO) is a recently characterized cysteine containing enzyme with the capability to
bind and release GSH in vitro. GSTO has not been investigated in human lung or lung …
oxidant/antioxidant imbalance and possibly impaired antioxidant defence. Glutathione
(GSH) is one of the most important antioxidants in human lung and lung secretions, but the
mechanisms participating in its homeostasis are partly unclear. Glutathione-S-transferase
omega (GSTO) is a recently characterized cysteine containing enzyme with the capability to
bind and release GSH in vitro. GSTO has not been investigated in human lung or lung …
Background
The major contribution to oxidant related lung damage in COPD is from the oxidant/antioxidant imbalance and possibly impaired antioxidant defence. Glutathione (GSH) is one of the most important antioxidants in human lung and lung secretions, but the mechanisms participating in its homeostasis are partly unclear. Glutathione-S-transferase omega (GSTO) is a recently characterized cysteine containing enzyme with the capability to bind and release GSH in vitro. GSTO has not been investigated in human lung or lung diseases.
Methods
GSTO1-1 was investigated by immunohistochemistry and Western blot analysis in 72 lung tissue specimens and 40 sputum specimens from non-smokers, smokers and COPD, in bronchoalveolar lavage fluid and in plasma from healthy non-smokers and smokers. It was also examined in human monocytes and bronchial epithelial cells and their culture mediums in vitro.
Results
GSTO1-1 was mainly expressed in alveolar macrophages, but it was also found in airway and alveolar epithelium and in extracellular fluids including sputum supernatants, bronchoalveolar lavage fluid, plasma and cell culture mediums. The levels of GSTO1-1 were significantly lower in the sputum supernatants (p = 0.023) and lung homogenates (p = 0.003) of COPD patients than in non-smokers.
Conclusion
GSTO1-1 is abundant in the alveolar macrophages, but it is also present in extracellular fluids and in airway secretions, the levels being decreased in COPD. The clinical significance of GSTO1-1 and its role in regulating GSH homeostasis in airway secretions, however, needs further investigations.
Springer